{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:39:15Z","timestamp":1792744755836,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"DOI":"10.1038\/s41585-026-01198-9","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:01:22Z","timestamp":1792742482000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome interactions in renal cell carcinoma: evidence, challenges and opportunities"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6813-5665","authenticated-orcid":false,"given":"Cecilie","family":"Lindgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-1846","authenticated-orcid":false,"given":"Astrid Korning","family":"Hvidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Krarup","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Thingholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Schou","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3446-1182","authenticated-orcid":false,"given":"Iben","family":"Lyskj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"1198_CR1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","volume":"35","author":"T Powles","year":"2024","unstructured":"Powles, T. et al. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 35, 692\u2013706 (2024).","journal-title":"Ann. Oncol."},{"key":"1198_CR2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal. Cell 173, 595\u2013610.e11 (2018).","journal-title":"Cell"},{"key":"1198_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal. Cell 173, 581\u2013594.e12 (2018).","journal-title":"Cell"},{"key":"1198_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa1712126","volume":"378","author":"RJ Motzer","year":"2018","unstructured":"Motzer, R. J. et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. N. Engl. J. Med. 378, 1277\u20131290 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1198_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eururo.2020.10.022","volume":"79","author":"SL Gomez","year":"2021","unstructured":"Gomez, S. L. et al. Monitoring prostate cancer incidence trends: value of multiple imputation and delay adjustment to discern disparities in stage-specific trends. Eur. Urol. 79, 42\u201343 (2021).","journal-title":"Eur. Urol."},{"key":"1198_CR6","doi-asserted-by":"publisher","unstructured":"Lyskj\u00e6r, I. et al. Management of renal cell carcinoma: promising biomarkers and the challenges to reach the clinic. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1892 (2024).","DOI":"10.1158\/1078-0432.CCR-23-1892"},{"key":"1198_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00875-0","volume":"8","author":"G Berg","year":"2020","unstructured":"Berg, G. et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome 8, 103 (2020).","journal-title":"Microbiome"},{"key":"1198_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nature24621","volume":"551","author":"LR Thompson","year":"2017","unstructured":"Thompson, L. R. et al. A communal catalogue reveals Earth\u2019s multiscale microbial diversity. Nature 551, 457\u2013463 (2017).","journal-title":"Nature"},{"key":"1198_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol. 31, 69\u201375 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1198_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06164-4","volume":"23","author":"L Ma","year":"2025","unstructured":"Ma, L. et al. Circulating microbiome DNA features and its effect on predicting clinicopathological characteristics of patients with colorectal cancer. J. Transl. Med. 23, 178 (2025).","journal-title":"J. Transl. Med."},{"key":"1198_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"1198_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41591-024-02823-z","volume":"30","author":"A Gunjur","year":"2024","unstructured":"Gunjur, A. et al. A gut microbial signature for combination immune checkpoint blockade across cancer types. Nat. Med. 30, 797\u2013809 (2024).","journal-title":"Nat. Med."},{"key":"1198_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"1198_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19940-1","volume":"11","author":"L Tian","year":"2020","unstructured":"Tian, L. et al. Deciphering functional redundancy in the human microbiome. Nat. Commun. 11, 6217 (2020).","journal-title":"Nat. Commun."},{"key":"1198_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2024.12.017","volume":"188","author":"RJ Abdill","year":"2025","unstructured":"Abdill, R. J. et al. Integration of 168,000 samples reveals global patterns of the human gut microbiome. Cell 188, 1100\u20131118.e17 (2025).","journal-title":"Cell"},{"key":"1198_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000504029","volume":"104","author":"S Heidler","year":"2020","unstructured":"Heidler, S., Lusuardi, L., Madersbacher, S. & Freibauer, C. The microbiome in benign renal tissue and in renal cell carcinoma. Urol. Int. 104, 247\u2013252 (2020).","journal-title":"Urol. Int."},{"key":"1198_CR17","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1128\/AEM.01451-14","volume":"80","author":"K Kennedy","year":"2014","unstructured":"Kennedy, K., Hall, M. W., Lynch, M. D. J., Moreno-Hagelsieb, G. & Neufeld, J. D. Evaluating bias of illumina-based bacterial 16S rRNA gene profiles. Appl. Environ. Microbiol. 80, 5717\u20135722 (2014).","journal-title":"Appl. Environ. Microbiol."},{"key":"1198_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2516703","volume":"17","author":"Y Hui","year":"2025","unstructured":"Hui, Y., Sandris Nielsen, D. & Krych, L. De novo clustering of long-read amplicons improves phylogenetic insight into microbiome data. Gut Microbes 17, 2516703 (2025).","journal-title":"Gut Microbes"},{"key":"1198_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01670-24","volume":"63","author":"VL Campod\u00f3nico","year":"2025","unstructured":"Campod\u00f3nico, V. L. et al. Evaluation of long-read 16S rRNA next-generation sequencing for identification of bacterial isolates in a clinical diagnostic laboratory. J. Clin. Microbiol. 63, e0167024 (2025).","journal-title":"J. Clin. Microbiol."},{"key":"1198_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqac090","volume":"4","author":"M Zeller","year":"2022","unstructured":"Zeller, M. & Huson, D. H. Comparison of functional classification systems. NAR Genom. Bioinform. 4, lqac090 (2022).","journal-title":"NAR Genom. Bioinform."},{"key":"1198_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"1198_CR22","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41564-026-02334-2","volume":"11","author":"NS Treichel","year":"2026","unstructured":"Treichel, N. S. et al. Benchmarking of shotgun sequencing depth reveals the potential and limitations of shallow metagenomics and strain-level analysis. Nat. Microbiol. 11, 1233\u20131244 (2026).","journal-title":"Nat. Microbiol."},{"key":"1198_CR23","doi-asserted-by":"publisher","DOI":"10.1099\/acmi.0.000104","volume":"2","author":"AJ McArdle","year":"2020","unstructured":"McArdle, A. J. & Kaforou, M. Sensitivity of shotgun metagenomics to host DNA: abundance estimates depend on bioinformatic tools and contamination is the main issue. Access. Microbiol. 2, acmi000104 (2020).","journal-title":"Access. Microbiol."},{"key":"1198_CR24","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/s41564-025-02035-2","volume":"10","author":"N Fierer","year":"2025","unstructured":"Fierer, N. et al. Guidelines for preventing and reporting contamination in low-biomass microbiome studies. Nat. Microbiol. 10, 1570\u20131580 (2025).","journal-title":"Nat. Microbiol."},{"key":"1198_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1182322","volume":"13","author":"J-X Sun","year":"2023","unstructured":"Sun, J.-X., Xia, Q.-D., Zhong, X.-Y., Liu, Z. & Wang, S.-G. The bladder microbiome of NMIBC and MIBC patients revealed by 2bRAD-M. Front. Cell. Infect. Microbiol. 13, 1182322 (2023).","journal-title":"Cell. Infect. Microbiol."},{"key":"1198_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01180-9","volume":"15","author":"G Sambruni","year":"2023","unstructured":"Sambruni, G. et al. Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data. Genome Med. 15, 32 (2023).","journal-title":"Genome Med."},{"key":"1198_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Ni\u00f1o","year":"2022","unstructured":"Galeano Ni\u00f1o, J. L. et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature 611, 810\u2013817 (2022).","journal-title":"Nature"},{"key":"1198_CR28","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885\u20131892 (2021).","journal-title":"Nat. Med."},{"key":"1198_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"1198_CR30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.eururo.2020.07.011","volume":"78","author":"NJ Salgia","year":"2020","unstructured":"Salgia, N. J. et al. Stool microbiome profiling of patients with metastatic renal cell carcinoma receiving anti-PD-1 immune checkpoint inhibitors. Eur. Urol. 78, 498\u2013502 (2020).","journal-title":"Eur. Urol."},{"key":"1198_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/1750743X.2025.2482510","volume":"17","author":"M Catalano","year":"2025","unstructured":"Catalano, M. et al. Incidence and impact of immune combination therapies adverse events in advanced renal cell carcinoma patients. Immunotherapy 17, 247\u2013256 (2025).","journal-title":"Immunotherapy"},{"key":"1198_CR32","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/s41591-025-04183-8","volume":"32","author":"R Fernandes","year":"2026","unstructured":"Fernandes, R. et al. Fecal microbiota transplantation plus immunotherapy in metastatic renal cell carcinoma: the phase 1 PERFORM trial. Nat. Med. 32, 1325\u20131336 (2026).","journal-title":"Nat. Med."},{"key":"1198_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18127-y","volume":"11","author":"G Ianiro","year":"2020","unstructured":"Ianiro, G. et al. Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma. Nat. Commun. 11, 4333 (2020).","journal-title":"Nat. Commun."},{"key":"1198_CR34","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1038\/s41591-024-03086-4","volume":"30","author":"H Ebrahimi","year":"2024","unstructured":"Ebrahimi, H. et al. Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat. Med. 30, 2576\u20132585 (2024).","journal-title":"Nat. Med."},{"key":"1198_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.annonc.2024.12.003","volume":"36","author":"RJ Motzer","year":"2025","unstructured":"Motzer, R. J. et al. Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. Ann. Oncol. 36, 375\u2013386 (2025).","journal-title":"Ann. Oncol."},{"key":"1198_CR36","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","volume":"26","author":"DA Braun","year":"2020","unstructured":"Braun, D. A. et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat. Med. 26, 909\u2013918 (2020).","journal-title":"Nat. Med."},{"key":"1198_CR37","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1200\/JCO.2020.38.6_suppl.730","volume":"38","author":"A Agarwal","year":"2020","unstructured":"Agarwal, A. et al. Investigating the role of the gastrointestinal microbiome in response to immune checkpoint inhibitors (ICIs) among patients (pts) with metastatic renal cell carcinoma (mRCC). J. Clin. Oncol. 38, 730\u2013730 (2020).","journal-title":"J. Clin. Oncol."},{"key":"1198_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00819-2","volume":"11","author":"L Huang","year":"2025","unstructured":"Huang, L. et al. Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors. npj Biofilms Microbiomes 11, 180 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"1198_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480\u2013484 (2009).","journal-title":"Nature"},{"key":"1198_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565\u2013569 (2016).","journal-title":"Science"},{"key":"1198_CR41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559\u2013563 (2014).","journal-title":"Nature"},{"key":"1198_CR42","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41564-018-0257-9","volume":"3","author":"A Palleja","year":"2018","unstructured":"Palleja, A. et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat. Microbiol. 3, 1255\u20131265 (2018).","journal-title":"Nat. Microbiol."},{"key":"1198_CR43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"1198_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.eururo.2020.04.044","volume":"78","author":"L Derosa","year":"2020","unstructured":"Derosa, L. et al. Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients. Eur. Urol. 78, 195\u2013206 (2020).","journal-title":"Eur. Urol."},{"key":"1198_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cam4.3569","volume":"10","author":"N Dizman","year":"2021","unstructured":"Dizman, N. et al. Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma. Cancer Med. 10, 79\u201386 (2021).","journal-title":"Cancer Med."},{"key":"1198_CR46","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman, N. et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat. Med. 28, 704\u2013712 (2022).","journal-title":"Nat. Med."},{"key":"1198_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2025.102450","volume":"23","author":"MS Jespersen","year":"2025","unstructured":"Jespersen, M. S. et al. Nationwide real-world outcomes of trial eligible and trial ineligible patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab. Clin. Genitourin. Cancer 23, 102450 (2025).","journal-title":"Clin. Genitourin. Cancer"},{"key":"1198_CR48","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/2159-8290.CD-21-0808","volume":"12","author":"M Messaoudene","year":"2022","unstructured":"Messaoudene, M. et al. A natural polyphenol exerts antitumor activity and circumvents anti-PD-1 resistance through effects on the gut microbiota. Cancer Discov. 12, 1070\u20131087 (2022).","journal-title":"Cancer Discov."},{"key":"1198_CR49","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1200\/JCO.2025.43.16_suppl.4529","volume":"43","author":"L Derosa","year":"2025","unstructured":"Derosa, L. et al. Phase 1 results of Oncobax-AK in combination with ipilimumab\/nivolumab in advanced clear cell renal cell carcinoma (ccRCC; NCT05865730). J. Clin. Oncol. 43, 4529\u20134529 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1198_CR50","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.annonc.2026.02.017","volume":"37","author":"TK Choueiri","year":"2026","unstructured":"Choueiri, T. K. et al. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial. Ann. Oncol. 37, 960\u2013973 (2026).","journal-title":"Ann. Oncol."},{"key":"1198_CR51","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00262-022-03329-8","volume":"72","author":"M Ninkov","year":"2023","unstructured":"Ninkov, M. et al. Improved MAIT cell functions following fecal microbiota transplantation for metastatic renal cell carcinoma. Cancer Immunol. Immunother. 72, 1247\u20131260 (2023).","journal-title":"Cancer Immunol. Immunother."},{"key":"1198_CR52","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s41591-025-04189-2","volume":"32","author":"S Porcari","year":"2026","unstructured":"Porcari, S. et al. Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial. Nat. Med. 32, 1316\u20131324 (2026).","journal-title":"Nat. Med."},{"key":"1198_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-09156-x","volume":"22","author":"NA Thompson","year":"2022","unstructured":"Thompson, N. A. et al. The MITRE trial protocol: a study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy. BMC Cancer 22, 99 (2022).","journal-title":"BMC Cancer"},{"key":"1198_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11987-3","volume":"24","author":"L Iisager","year":"2024","unstructured":"Iisager, L. et al. Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial. BMC Cancer 24, 260 (2024).","journal-title":"BMC Cancer"},{"key":"1198_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071516","volume":"10","author":"OV Kovaleva","year":"2022","unstructured":"Kovaleva, O. V. et al. Macrophage phenotype in combination with tumor microbiome composition predicts RCC patients\u2019 survival: A pilot study. Biomedicines 10, 1516 (2022).","journal-title":"Biomedicines"},{"key":"1198_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38310","volume":"10","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Tumor microbiota of renal cell carcinoma affects clinical prognosis by influencing the tumor immune microenvironment. Heliyon 10, e38310 (2024).","journal-title":"Heliyon"},{"key":"1198_CR57","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00432-020-03462-w","volume":"147","author":"J Wang","year":"2021","unstructured":"Wang, J. et al. Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing. J. Cancer Res. Clin. Oncol. 147, 481\u2013491 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1198_CR58","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adu1727","volume":"11","author":"W Mou","year":"2025","unstructured":"Mou, W. et al. Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma. Sci. Adv. 11, eadu1727 (2025).","journal-title":"Sci. Adv."},{"key":"1198_CR59","doi-asserted-by":"publisher","unstructured":"Martin, A. C. et al. Intratumoural bacteria promote myeloid inflammation and disease progression in clear cell renal cell carcinoma: TRACERx Renal. Preprint at Cell Press https:\/\/doi.org\/10.2139\/ssrn.6690545 (2026).","DOI":"10.2139\/ssrn.6690545"},{"key":"1198_CR60","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/iai.15.2.621-627.1977","volume":"15","author":"GJ Domingue","year":"1977","unstructured":"Domingue, G. J. & Schlegel, J. U. Novel bacterial structures in human blood: cultural isolation. Infect. Immun. 15, 621\u2013627 (1977).","journal-title":"Infect. Immun."},{"key":"1198_CR61","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1128\/JCM.39.5.1956-1959.2001","volume":"39","author":"S Nikkari","year":"2001","unstructured":"Nikkari, S., McLaughlin, I. J., Bi, W., Dodge, D. E. & Relman, D. A. Does blood of healthy subjects contain bacterial ribosomal DNA? J. Clin. Microbiol. 39, 1956\u20131959 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"1198_CR62","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41564-023-01350-w","volume":"8","author":"CCS Tan","year":"2023","unstructured":"Tan, C. C. S. et al. No evidence for a common blood microbiome based on a population study of 9,770 healthy humans. Nat. Microbiol. 8, 973\u2013985 (2023).","journal-title":"Nat. Microbiol."},{"key":"1198_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2560605","volume":"57","author":"Z Zhang","year":"2025","unstructured":"Zhang, Z., Ren, W., Wang, Y., Zhai, T. & Huang, J. The origin of circulating microbial DNA in the blood: where does it come from? Ann. Med. 57, 2560605 (2025).","journal-title":"Ann. Med."},{"key":"1198_CR64","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567\u2013574 (2020).","journal-title":"Nature"},{"key":"1198_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101499","volume":"5","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell Rep. Med. 5, 101499 (2024).","journal-title":"Cell Rep. Med."},{"key":"1198_CR66","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00276-25","volume":"10","author":"Z Zhou","year":"2025","unstructured":"Zhou, Z. et al. Microbiome and fragmentation pattern of blood cell-free DNA and fecal metagenome enhance colorectal cancer micro-dysbiosis and diagnosis analysis: a proof-of-concept study. mSystems 10, e0027625 (2025).","journal-title":"mSystems"},{"key":"1198_CR67","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01607-23","volume":"14","author":"A Gihawi","year":"2023","unstructured":"Gihawi, A. et al. Major data analysis errors invalidate cancer microbiome findings. mBio 14, e0160723 (2023).","journal-title":"mBio"},{"key":"1198_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16020394","volume":"16","author":"M Uzelac","year":"2024","unstructured":"Uzelac, M. et al. Urinary microbiome dysbiosis and immune dysregulations as potential diagnostic indicators of bladder cancer. Cancers 16, 394 (2024).","journal-title":"Cancers"},{"key":"1198_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13164927","volume":"13","author":"R Pallares-Mendez","year":"2024","unstructured":"Pallares-Mendez, R., Brassetti, A., Bove, A. M. & Simone, G. Insights into the interplay between the urinary microbiome and bladder cancer: a comprehensive review. J. Clin. Med. 13, 4927 (2024).","journal-title":"J. Clin. Med."},{"key":"1198_CR70","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4111\/icu.20220124","volume":"63","author":"HK Ahn","year":"2022","unstructured":"Ahn, H. K., Kim, K., Park, J. & Kim, K. H. Urinary microbiome profile in men with genitourinary malignancies. Investig. Clin. Urol. 63, 569\u2013576 (2022).","journal-title":"Investig. Clin. Urol."},{"key":"1198_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.70186","volume":"7","author":"F Leal","year":"2026","unstructured":"Leal, F. et al. Urinary microbiota diversity and composition in patients with advanced renal cell cancer. BJUI Compass 7, e70186 (2026).","journal-title":"BJUI Compass"},{"key":"1198_CR72","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104\u2013108 (2018).","journal-title":"Science"},{"key":"1198_CR73","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s42255-022-00670-1","volume":"4","author":"C Diener","year":"2022","unstructured":"Diener, C. et al. Genome-microbiome interplay provides insight into the determinants of the human blood metabolome. Nat. Metab. 4, 1560\u20131572 (2022).","journal-title":"Nat. Metab."},{"key":"1198_CR74","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1038\/s41591-022-02014-8","volume":"28","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. Influence of the microbiome, diet and genetics on inter-individual variation in the human plasma metabolome. Nat. Med. 28, 2333\u20132343 (2022).","journal-title":"Nat. Med."},{"key":"1198_CR75","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41592-018-0176-y","volume":"15","author":"EA Franzosa","year":"2018","unstructured":"Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962\u2013968 (2018).","journal-title":"Nat. Methods"},{"key":"1198_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.10.007","volume":"6","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. Effects of gut microbiota on immune checkpoint inhibitors in multi-cancer and as microbial biomarkers for predicting therapeutic response. Med 6, 100530 (2025).","journal-title":"Med"},{"key":"1198_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/2326-6066.CIR-14-0225","volume":"3","author":"RS Goldszmid","year":"2015","unstructured":"Goldszmid, R. S. et al. Microbiota modulation of myeloid cells in cancer therapy. Cancer Immunol. Res. 3, 103\u2013109 (2015).","journal-title":"Cancer Immunol. Res."},{"key":"1198_CR78","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.abc3421","volume":"369","author":"LF Mager","year":"2020","unstructured":"Mager, L. F. et al. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369, 1481\u20131489 (2020).","journal-title":"Science"},{"key":"1198_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16079-x","volume":"11","author":"C Coutzac","year":"2020","unstructured":"Coutzac, C. et al. Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer. Nat. Commun. 11, 2168 (2020).","journal-title":"Nat. Commun."},{"key":"1198_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04142-y","volume":"26","author":"Q-C Wang","year":"2025","unstructured":"Wang, Q.-C. et al. Circulating bile acid profiles characteristics and the potential predictive role in clear cell renal cell carcinoma progression. BMC Nephrol. 26, 206 (2025).","journal-title":"BMC Nephrol."},{"key":"1198_CR81","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller, L. T. et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357, 1156\u20131160 (2017).","journal-title":"Science"},{"key":"1198_CR82","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1158\/0008-5472.CAN-22-2593","volume":"83","author":"H Wu","year":"2023","unstructured":"Wu, H. et al. Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma. Cancer Res. 83, 3131\u20133144 (2023).","journal-title":"Cancer Res."},{"key":"1198_CR83","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert, L. E. et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell 41, 1945\u20131962.e11 (2023).","journal-title":"Cancer Cell"},{"key":"1198_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24525","volume":"40","author":"Y Xia","year":"2025","unstructured":"Xia, Y. et al. RETRACTION: integrated analysis of gut microbiota and metabolomic profiling in colorectal cancer metastasis. Environ. Toxicol. 40, 1044 (2025).","journal-title":"Environ. Toxicol."},{"key":"1198_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30512-3","volume":"13","author":"LC Hermida","year":"2022","unstructured":"Hermida, L. C., Gertz, E. M. & Ruppin, E. Predicting cancer prognosis and drug response from the tumor microbiome. Nat. Commun. 13, 2896 (2022).","journal-title":"Nat. Commun."},{"key":"1198_CR86","doi-asserted-by":"publisher","DOI":"10.1111\/srt.70017","volume":"30","author":"L Sun","year":"2024","unstructured":"Sun, L., Ying, J., Guo, R., Jia, L. & Zhang, H. A bibliometric analysis of global research on microbial immune microenvironment in melanoma from 2012 to 2022. Skin Res. Technol. 30, e70017 (2024).","journal-title":"Skin Res. Technol."},{"key":"1198_CR87","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer, R. et al. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 27, 105\u2013117 (2019).","journal-title":"Trends Microbiol."},{"key":"1198_CR88","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41564-018-0202-y","volume":"3","author":"MC de Goffau","year":"2018","unstructured":"de Goffau, M. C. et al. Recognizing the reagent microbiome. Nat. Microbiol. 3, 851\u2013853 (2018).","journal-title":"Nat. Microbiol."},{"key":"1198_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017288","volume":"6","author":"R Schmieder","year":"2011","unstructured":"Schmieder, R. & Edwards, R. Fast identification and removal of sequence contamination from genomic and metagenomic datasets. PLoS ONE 6, e17288 (2011).","journal-title":"PLoS ONE"},{"key":"1198_CR90","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"1198_CR91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"key":"1198_CR92","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"SF Altschul","year":"1990","unstructured":"Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403\u2013410 (1990).","journal-title":"J. Mol. Biol."},{"key":"1198_CR93","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1198_CR94","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069\u20135072 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"1198_CR95","doi-asserted-by":"publisher","first-page":"D785","DOI":"10.1093\/nar\/gkab776","volume":"50","author":"DH Parks","year":"2022","unstructured":"Parks, D. H. et al. GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy. Nucleic Acids Res. 50, D785\u2013D794 (2022).","journal-title":"Nucleic Acids Res."},{"key":"1198_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2022.905489","volume":"2","author":"Y-P Hsieh","year":"2022","unstructured":"Hsieh, Y.-P., Hung, Y.-M., Tsai, M.-H., Lai, L.-C. & Chuang, E. Y. 16S-ITGDB: an integrated database for improving species classification of prokaryotic 16S ribosomal RNA sequences. Front. Bioinform. 2, 905489 (2022).","journal-title":"Front. Bioinform."},{"key":"1198_CR97","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","volume":"376","author":"S Nurk","year":"2022","unstructured":"Nurk, S. et al. The complete sequence of a human genome. Science 376, 44\u201353 (2022).","journal-title":"Science"},{"key":"1198_CR98","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"1000 Genomes Project Consortium.","year":"2015","unstructured":"1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"1198_CR99","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633\u20131644 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1198_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01410-z","volume":"10","author":"H-J Ruscheweyh","year":"2022","unstructured":"Ruscheweyh, H.-J. et al. Cultivation-independent genomes greatly expand taxonomic-profiling capabilities of mOTUs across various environments. Microbiome 10, 212 (2022).","journal-title":"Microbiome"},{"key":"1198_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"1198_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1419-2","volume":"16","author":"R Ounit","year":"2015","unstructured":"Ounit, R., Wanamaker, S., Close, T. J. & Lonardi, S. CLARK: fast and accurate classification of metagenomic and genomic sequences using discriminative k-mers. BMC Genomics 16, 236 (2015).","journal-title":"BMC Genomics"},{"key":"1198_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1169101","volume":"13","author":"Y Hou","year":"2023","unstructured":"Hou, Y. et al. Microbial signatures of neonatal bacterial meningitis from multiple body sites. Front. Cell. Infect. Microbiol. 13, 1169101 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1198_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0605-2","volume":"6","author":"NM Davis","year":"2018","unstructured":"Davis, N. M., Proctor, D. M., Holmes, S. P., Relman, D. A. & Callahan, B. J. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome 6, 226 (2018).","journal-title":"Microbiome"},{"key":"1198_CR105","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1568812","volume":"8","author":"A Elkrief","year":"2019","unstructured":"Elkrief, A. et al. Antibiotics are associated with decreased progression-free survival of advanced melanoma patients treated with immune checkpoint inhibitors. Oncoimmunology 8, e1568812 (2019).","journal-title":"Oncoimmunology"},{"key":"1198_CR106","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s12029-024-01016-8","volume":"55","author":"JE Persson","year":"2024","unstructured":"Persson, J. E., Viana, P., Persson, M., Relvas, J. H. & Danielski, L. G. Perioperative or postoperative probiotics reduce treatment-related complications in adult colorectal cancer patients undergoing surgery: a systematic review and meta-analysis. J. Gastrointest. Cancer 55, 740\u2013748 (2024).","journal-title":"J. Gastrointest. Cancer"},{"key":"1198_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03296-3","volume":"16","author":"J Cui","year":"2025","unstructured":"Cui, J. et al. Gut microbiota and urological cancers: from microecological imbalance to potential for precision therapy. Discov. Oncol. 16, 1799 (2025).","journal-title":"Discov. Oncol."},{"key":"1198_CR108","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2106391","volume":"385","author":"TK Choueiri","year":"2021","unstructured":"Choueiri, T. K. et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N. Engl. J. Med. 385, 683\u2013694 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1198_CR109","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","volume":"390","author":"TK Choueiri","year":"2024","unstructured":"Choueiri, T. K. et al. Overall survival with adjuvant pembrolizumab in renal-cell carcinoma. N. Engl. J. Med. 390, 1359\u20131371 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1198_CR110","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT07383441 (2026)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01198-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01198-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:01:24Z","timestamp":1792742484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-026-01198-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":110,"alternative-id":["1198"],"URL":"https:\/\/doi.org\/10.1038\/s41585-026-01198-9","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"28 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}